Brief: Organon Q1 Adjusted EPS USD 1.02 Vs. IBES Estimate USD 0.9
01/05/2025 12:00
May 01 (Reuters) - Organon Q1 revenue USD 1,513 million vs. IBES estimate USD 1,508 million. Q1 EPS USD 0.33 Q1 adjusted EBITDA margin 32% Q1 net income USD 87 million Q1 gross margin 55.6% Q1 adjusted EBITDA USD 484 million Q1 adjusted net income USD 265 million vs. IBES estimate USD 239.5 million
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary